Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Nuwellis Inc (NUWE) vs Opendoor Technologies Inc (OPEN) Price & Performance

Nuwellis IncTrade
Opendoor Technologies IncTrade

Price performance (Past 24H)

Key statistics

Nuwellis Inc vs Opendoor Technologies Inc — how do they compare? Nuwellis Inc trades at $0.69 (market cap $2.20M), while Opendoor Technologies Inc trades at $2.25 (market cap $2.22B). The key difference: Opendoor Technologies Inc is far larger — about 1009.1× Nuwellis Inc's market cap, and Nuwellis Inc is more actively traded (121,544 versus 28,705,892). Which is the better fit depends on your goals — on Pluang, investors hold Nuwellis Inc for 26 Days and Opendoor Technologies Inc for 33 Days on average.

NUWEOPEN
Market Cap
$2.20M$2.22B
Volume
121,54428,705,892
Sector
HealthReal Estate
52-Week High
$146.65$9.37
52-Week Low
$0.68$2.27
Typical Hold Time
26 Days33 Days
Enterprise Value
-$1.52M$3.29B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Nuwellis Inc

NUWE trades at $0.6907, down 1.48% on the day, with a bearish technical signal from moving averages despite oversold RSI readings. The company reported revenue growth to $9M in 2026 but remains deeply unprofitable with a net income margin of -125.63%. Recent news highlights console sales growth and strategic expansions in pediatric and critical care markets.

The outlook is high-risk due to persistent losses and negative cash flow, though analyst sentiment is split with a 50% buy rating. Investment potential hinges on the company's ability to achieve profitability and scale its Aquadex platform, while risks include cash burn and competitive pressures in the medical device sector.

Opendoor Technologies Inc

Opendoor Technologies (OPEN) trades at $2.27 with no recent price movement, reflecting ongoing investor caution. The stock shows bearish technical signals with most moving averages and oscillators indicating selling pressure. Fundamentally, the company continues to struggle with profitability, posting a -46.74% net income margin and -$1.30B net loss in 2025 despite $4.37B revenue. Recent news highlights the company's mortgage expansion strategy and ongoing challenges in the housing market.

While analyst consensus suggests significant upside potential with a $4.92 price target, the company faces substantial execution risks amid persistent losses and high debt levels. The path to profitability remains uncertain, with revenue declining from $15.6B in 2022 to $4.4B in 2025. Investors should weigh the discounted valuation against ongoing operational challenges in the volatile housing sector.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NUWE
40% Buy60% Sell
Avg holding period · 26 Days
OPEN
20% Buy80% Sell
Avg holding period · 33 Days

Top news

Latest headlines on both assets

About Nuwellis Inc

Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.

Read more on NUWE →

About Opendoor Technologies Inc

Opendoor Technologies Inc is a digital platform for residential real estate. This platform enables customers to buy and sell houses online. It generates revenue through home sales, along with other revenue from real estate services.

Read more on OPEN →